ArticleAnnals of surgical oncology2025
Optimal Number of Lymph Nodes Retrieved to Lower the Risk of False N0 for Patients with Pancreatic Cancer Undergoing Curative Surgery.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAccurate LN examination is critical for staging and prognosis in pancreatic cancer. However, the ideal number of LNs required for precise staging and improved survival remains unclear. This study aimed to determine the optimal number of lymph nodes (LNs) to retrieve during pancreatectomy for pancreatic cancer to minimize false node-negative (false N0) rates and assess its impact on survival outcomes.
methodsThis retrospective cohort study analyzed data from patients undergoing curative-intent upfront surgery for pancreatic cancer at two tertiary centers in South Korea (2010-2021). An exploration cohort of 808 patients was used to identify LN retrieval thresholds, and the results were validated in an independent cohort of 444 patients. The study excluded patients who received neoadjuvant therapy or had fewer than two retrieved LNs. False N0 rates and 5 year overall survival were analyzed.
resultsIn the exploration cohort, examining 16 LNs reduced the false N0 rate to 18.9%, whereas in the validation cohort, retrieving 12 LNs resulted in a false N0 rate of 19.5%. Among the node-negative (N0) patients, retrieving up to 21 LNs was associated with improved 5 year overall survival. Differences in cutoff values between cohorts were attributed to demographic variations and inclusion of fewer LNs retrieved but higher detection of metastatic nodes in the validation cohort.
conclusionsRetrieving a sufficient number of LNs during pancreatectomy is essential to reducing false N0 rates and improving survival outcomes for pancreatic cancer patients. These findings highlight the need for standardized LN evaluation protocols and support further prospective, multi-center studies to optimize staging accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.